Phase 3 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with a specific type of nasopharyngeal carcinoma (a cancer of the upper throat area behind the nose), confirmed by tissue testing, classified as WHO Type II or III (non-keratinizing)
- People whose cancer has been staged as Stage III or IVa, with specific stage combinations as defined by medical staging guidelines (confirm with trial site)
- People whose cancer has not spread to distant parts of the body
- People aged between 18 and 65 years old
- People whose blood cell counts meet required levels — including white blood cells, platelets, and haemoglobin — as confirmed by blood tests
- People whose liver is functioning within acceptable ranges, as confirmed by blood tests
- People whose kidneys are functioning within acceptable ranges, as confirmed by blood or urine tests
- People who are considered well enough to carry out daily activities, as measured by a standard health performance scale (score above 70 out of 100)
- People who have given their written agreement to participate in the trial
Who may not be able to join:
- People whose tissue testing confirms a different type of nasopharyngeal carcinoma, classified as WHO Type I (keratinizing)
- People younger than 18 or older than 65 years of age
- People whose treatment is intended only to manage symptoms rather than to treat the cancer directly
- People who have had another type of cancer in the past, with the exception of certain treated skin cancers or early-stage cervical cancer
- People who have previously received radiotherapy, chemotherapy, or surgery (other than for diagnostic purposes) to the affected area
- People who are pregnant or currently breastfeeding
- People living with serious ongoing health conditions that could create unacceptable risks or make it difficult to follow the trial requirements — such as unstable heart disease, severe breathing difficulties requiring hospital admission, active hepatitis, or significant mental health conditions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jinquan Liu, M.D, Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phone: 0086-137-1086-6485
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progress-Free Survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.